ArticleAnnals of the American Thoracic Society2021
Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
Erratum issuedOpen access · greenAbstract read
In one paragraph
Article in Annals of the American Thoracic Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 45 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.
- Effect of amphetamines on blood pressure.The Cochrane database of systematic reviews · 2025Pooled it
- Effect of Famotidine on Outcomes in Pulmonary Arterial Hypertension: A Randomized Controlled Trial.Chest · 2025Trial
- Characteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and Ethnicity.Journal of racial and ethnic health disparities · 2026Observational
- Article
- Comparison of Functional and Hemodynamic Parameters Between Methamphetamine-Associated and Idiopathic Pulmonary Arterial Hypertension: Systematic Review and Meta-Analysis.Healthcare (Basel, Switzerland) · 2026Review
- Divergent Inflammatory and Bioenergetic Metabolomic Signatures Distinguish Methamphetamine-Associated From Idiopathic Pulmonary Arterial Hypertension.Pulmonary circulation · 2026Article
- Exposure Pattern Determines Methamphetamine-Induced Right Ventricular Dysfunction and Vascular Remodeling.Comprehensive Physiology · 2026Article
- Expert Consensus to Explore the Definition and Characterization of Methamphetamine-Associated Pulmonary Arterial Hypertension and Key Treatment Considerations.CHEST pulmonary · 2026Article
- Qualitative Interviews of Physicians Managing Patients With Methamphetamine-Associated Pulmonary Arterial Hypertension: Understanding the Unmet Medical Needs From a Provider Lens.Pulmonary circulation · 2026Article
- Methamphetamine-Associated Pulmonary Arterial Hypertension: Impact, Mechanisms, and a Framework for Management.Pulmonary circulation · 2026Review
- Marked Improvement in Pulmonary Arterial Hypertension in 3 Patients with a History of Amphetamine-like Drug use and Comorbidities.The open respiratory medicine journal · 2026Article
- Treatment Response and Survival in Methamphetamine-Associated Pulmonary Arterial Hypertension.Journal of the American Heart Association · 2025Article
- Pulmonary arterial hypertension associated with exposure to toxic rapeseed oil.ERJ open research · 2025Article
- Long-term outcomes of Qing-Dai-induced pulmonary arterial hypertension.ERJ open research · 2025Article
- Drugs and toxins associated with pulmonary arterial hypertension: from established culprits to novel threats.ERJ open research · 2025Review
- CircRNA-based AntimiR therapy: A novel approach to hypertension treatment.Non-coding RNA research · 2025Review
- Medication Nonadherence in Patients with Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR).Annals of the American Thoracic Society · 2025Article
- Methamphetamine-Associated Pulmonary Arterial Hypertension Is Associated With Worse Right Ventricular Function Than Idiopathic Pulmonary Arterial Hypertension: A Matched Study.Echocardiography (Mount Kisco, N.Y.) · 2025Article
- Exploring Providers' Behaviors, Attitudes, and Preferences on the Treatment of Pulmonary Arterial Hypertension With Endothelin Receptor Antagonist (ERA) + Phosphodiesterase-5 Inhibitors (PDE5i).Pulmonary circulation · 2025Article
- Trends in pulmonary arterial hypertension: insights from Global Burden of Disease 1990-2021.BMJ open · 2025Article
Corrections and comments
- Commented on by
- Erratum issued
Authors and funding
22 authors at 17 institutions in 1 country.
Nicholas A KolaitisDepartment of Medicine and.ORCID 0000-0002-4586-959X
Roham T ZamanianDepartment of Medicine, Stanford University School of Medicine, Palo Alto, California.
Vinicio A de Jesus PerezDepartment of Medicine, Stanford University School of Medicine, Palo Alto, California.
David B BadeschDepartment of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado.
Raymond L BenzaCardiovascular Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania.
Charles D BurgerDepartment of Medicine, Mayo Clinic Florida, Jacksonville, Florida.
Murali M ChakinalaDepartment of Medicine, Washington University, St. Louis, Missouri.
Jean M ElwingDepartment of Medicine, University of Cincinnati, Cincinnati, Ohio.
Jeremy FeldmanArizona Pulmonary Specialists, Phoenix, Arizona.
Matthew R LammiComprehensive Pulmonary Hypertension Center-University Medical Center, Louisiana State University, New Orleans, Louisiana.
Stephen C MathaiDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland.
John W McConnellKentuckiana Pulmonary Research Center, Kentuckiana Pulmonary Associates, Louisville, Kentucky.
Kenneth W PresbergDepartment of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Jeffrey C RobinsonThe Oregon Clinic, Portland, Oregon.
Jeffrey SagerCottage Pulmonary Hypertension Center, Cottage Health, Santa Barbara, California.
Oksana A ShlobinAdvanced Lung Disease and Lung Transplant Program, Inova Fairfax Medical Campus, Falls Church, Virginia.
Marc A SimonDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; and.
Steven M KawutDepartment of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
David V GliddenDepartment of Epidemiology and Biostatistics, University of California, San Francisco School of Medicine, San Francisco, California.
Jonathan P SingerDepartment of Medicine and.ORCID 0000-0003-0224-7472
Teresa De MarcoDepartment of Medicine and.
Pulmonary Hypertension Association Registry Investigators
Stanford University · USAllegheny General Hospital · USArizona Pain Specialists · USCottage Health · USInova Fairfax Hospital · USJacksonville College · USJohns Hopkins University · USKentuckiana Pulmonary Associates · USLouisiana State University · USMedical College of Wisconsin · USOregon Clinic · USUniversity of California, San Francisco · USUniversity of Cincinnati · USUniversity of Colorado Health · USUniversity of Pennsylvania · USUniversity of Pittsburgh · USWashington University in St. Louis · US
Funding
Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1MPhase II Trial of Metformin for Pulmonary Hypertension in Heart Failure with Preserved Ejection FractionR01AG058659 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SIMON, MARC A · 2018 to 2022
$3.2MMentored Patient-Oriented Research in Pulmonary Arterial HypertensionK24HL103844 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KAWUT, STEVEN M · 2011 to 2020
$1.6MNHLBI NIH HHS K24 HL103844NIA NIH HHS R01 AG058659NIGMS NIH HHS U54 GM104940
Abstract
PubMed holds no abstract for this paper.
Indexed as
Hypertension, PulmonaryMethamphetamineFamilial Primary Pulmonary HypertensionHumansProspective StudiesQuality of LifeRegistriesUnited StatesMethamphetaminedrug- and toxin-induced pulmonary arterial hypertensionhealth-related quality of lifeidiopathic pulmonary arterial hypertensionmethamphetamine-associated pulmonary arterial hypertensionPulmonary Hypertension Association Registry
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.